Cargando...
C(60) Fullerene as Synergistic Agent in Tumor-Inhibitory Doxorubicin Treatment
BACKGROUND: Doxorubicin (Dox) is one of the most potent anticancer drugs, but its successful use is hampered by high toxicity caused mainly by generation of reactive oxygen species. One approach to protect against Dox-dependent chemical insult is combined use of the cytostatic drug with antioxidants...
Gardado en:
| Publicado en: | Drugs R D |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4269825/ https://ncbi.nlm.nih.gov/pubmed/25504158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-014-0074-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|